X-FAB Silicon Foundries (XFAB) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Q2 2026 revenue ranged from $196.0M to $199.8M, down 7–10% year-over-year but up 2% sequentially, with bookings and backlog showing signs of recovery.
Core markets (automotive, industrial, medical) made up 93% of revenue; automotive saw inventory normalization and bookings improvement, while medical grew 39% year-over-year.
EBITDA was $33.6M, down 35% year-over-year, with margin at 16.8%; EBIT was $2.1M, down 90% year-over-year.
Strategic focus on AI-driven data center infrastructure, photonics, and wide bandgap technologies is accelerating, with several new design wins.
Financial highlights
Gross profit for Q2 was $30.5M (15.3% margin); EBITDA margin was 16.8% (17.6% excluding IFRS 15 impact).
Net loss for Q2 was $14.8M, impacted by a non-cash tax asset derecognition of $11.0M in Malaysia.
Cash and cash equivalents stood at $163.6M; net debt increased to $312.3M, up $20.9M sequentially.
CapEx for Q2 was $24.2M; first half 2026 CapEx totaled $50.2M.
Outlook and guidance
Q3 2026 revenue expected between $195M and $205M, with EBITDA margin guidance of 17–20%.
Management anticipates a stronger second half versus first half, with recovery expected to continue into Q4, though no formal Q4 guidance provided.
Cost-saving program initiated, with results expected by end of 2026.
Long-term revenue potential for data center applications estimated at $300M annually.
Latest events from X-FAB Silicon Foundries
- Q3 revenue up sequentially, automotive strong, industrial/medical weak, guidance lowered.XFAB
Q3 202426 Jun 2026 - Q4 2024 revenue and profit fell amid auto destocking; CapEx to drop and recovery expected in 2025.XFAB
Q4 202426 Jun 2026 - Q3 2025 revenue up 12% YoY to $229M, led by industrial and medical growth; order intake fell.XFAB
Q3 202526 Jun 2026 - Q1 2026 revenue was $195.6M, with strong growth in industrial, medical, and microsystems.XFAB
Q1 202610 May 2026 - Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 20259 Feb 2026 - Q2 revenue fell 9% year-on-year to $205.1M; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 20242 Feb 2026 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 202411 Jan 2026 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
Investor Day 202531 Dec 2025 - Q1 revenue up 8% sequentially, EBITDA margin 24%, guidance and expansion plans reaffirmed.XFAB
Q1 202523 Dec 2025